China Interventional Cardiovascular Device Industry Report, 2013-2015
  • Nov./2013
  • Hard Copy
  • USD $2,100
  • Pages:89
  • Single User License
    (PDF Unprintable)       
  • USD $2,000
  • Code: LT009
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,100
  • Hard Copy + Single User License
  • USD $2,300
With the accelerated aging, the prevalence of cardiovascular diseases in China increased year by year. According to statistics of National Health and Family Planning Commission of the People’s Republic of China, in 2012 cardiovascular disease deaths in China reached 3.5 million. The fast growing number of heart patients stimulated rapid growth in Chinese demand for interventional cardiac operation and coronary stent. China's PCI (percutaneous coronary intervention) surgeries increased from 25,000 cases in 2002 to about 531,000 cases in 2012; the number of coronary stent implantation rose from 40,000 units in 2002 to approximately 640,000 units in 2012. In 2007-2012 China's cardiovascular stent market size grew at an AAGR of 20.3%.


In China, interventional cardiovascular devices are dominated by cardiovascular stent. Currently, the top three companies in China's coronary stent market are respectively MicroPort, Lepu Medical and JW Medical; while supporting auxiliary devices such as catheter and guide wire feature low localization rate, mainly dependent on imports. In 2012, Chinese enterprises accounted for 66.8% of Chinese interventional cardiovascular device market share, followed by foreign counterparts with 33.2%.

Interventional cardiovascular device is a sunrise industry, there lies strong clinical demand for safer and more effective interventional products, and thus the world's major manufacturers have invested heavily in research and development of new products. Bioabsorbable everolimus-eluting stent (BVS) has become the focus of attention. Abbott in September 2012 launched the world's first A bioabsorbable everolimus-eluting coronary stent system (ABSORB), expected to bring a revolutionary change in coronary artery disease (CAD) treatment; MicroPort's third-generation completely biodegradable drug-eluting stent Firehawk has completed clinical trials in China; Lepu Medical's completely biodegradable drug-eluting stent is also in active research and development.

China Interventional Cardiovascular Device Industry Report, 2013-2015 mainly covers the followings:
20120114.gif Development, market demand, competition pattern, profit level, etc. of the industry;
20120114.gif Policy environment, impacts from upstream and downstream sectors, etc.;
20120114.gif Market size, supply and demand, product price, etc. of industry segments (including coronary stent, balloon catheter, guide wire, sheath group and auxiliary device), etc.;
20120114.gif Operation, interventional device cardiovascular business, operation in China, etc. of global companies (including Johnson & Johnson, Medtronic, Boston Scientific, Abbott Laboratories, B. Braun);
20120114.gif Operation, interventional cardiovascular device business, etc. of Chinese companies (including MicroPort, Lepu Medical, Lifetech Scientific, JW Medical, Liaoning Bio-medical Technology, OrbusNeich, SCW Medicath, Amtech Biotech and Starway Medical).

1. Overview of Interventional Cardiovascular Device Industry
1.1 Definition
1.2 Product Types and Applications
1.3 Industry Chain

2. Status Quo of China Interventional Cardiovascular Device Industry
2.1 Overview 
2.2 Market Demand 
2.3 Import and Export
2.4 Competition Pattern
2.5 Profit
2.6 Entry Barriers
2.6.1 Technology 
2.6.2 Talent 
2.6.3 Patent 
2.6.4 Policy 
2.6.5 Market Access 

3. Development Environment for China Interventional Cardiovascular Device Industry
3.1 Policy Environment
3.1.1 Regulatory Policy
3.1.2 Industry Policy
3.2 Upstream and Downstream Sectors
3.2.1 Upstream
3.2.2 Downstream

4. Market Segments
4.1 Coronary Stent
4.1.1 Market Profile
4.1.2 Drug-Eluting Stent
4.1.3 Bare Metal Stent
4.1.4 Bioabsorbable Stent
4.2 Balloon Catheter
4.2.1 Market Profile
4.2.2 Supply and Demand
4.3 Catheter
4.3.1 Market Profile
4.3.2 Sales
4.4 Guide Wire
4.4.1 Market Profile
4.4.2 Sales
4.5 Sheath Group and Auxiliary Devices
4.5.1 Market Profile
4.5.2 Sales

5. Foreign Companies
5.1 Johnson & Johnson
5.1.1 Profile
5.1.2 Operation
5.1.3 Interventional Cardiovascular Device Business
5.1.4 Operation in China
5.2 Medtronic
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 Operation in China
5.3 Boston Scientific
5.3.1 Profile
5.3.2 Operation
5.3.3 Operation in China
5.4 Abbott Laboratories
5.4.1 Profile
5.4.2 Operation
5.4.3 Operation in China
5.5 B. Braun
5.5.1 Profile
5.5.2 Operation
5.5.3 Operation in China

6. Chinese Companies
6.1 MicroPort
6.1.1 Profile
6.1.2 Operation
6.1.3 Revenue Structure
6.1.4 Gross Margin
6.1.5 R&D and Investment
6.1.6 Interventional Cardiovascular Device Business
6.1.7 Forecast and Outlook
6.2 Lepu Medical
6.2.1 Profile
6.2.2 Operation
6.2.3 Revenue Structure
6.2.4 Gross Margin
6.2.5 R&D and Investment
6.2.6 Interventional Cardiovascular Device Business
6.2.7 Forecast and Outlook
6.3 Lifetech Scientific
6.3.1 Profile
6.3.2 Operation
6.3.3 Revenue Structure
6.3.4 Gross Margin
6.3.5 R&D and Investment
6.3.6 Interventional Cardiovascular Device Business
6.4 JW Medical
6.4.1 Profile
6.4.2 Operation
6.4.3 Development
6.5 Liaoning Bio-medical
6.5.1 Profile
6.5.2 Operation
6.5.3 Development
6.6 OrbusNeich
6.6.1 Profile
6.6.2 Operation
6.6.3 Development
6.7 Sinomed
6.7.1 Profile
6.7.2 Operation
6.7.3 Development
6.8 SCW Medicath
6.8.1 Profile
6.8.2 Operation
6.9 Amtech Biotech
6.9.1 Profile
6.9.2 Operation 
6.10 Starway Medical
Interventional Cardiovascular Device Types and Functions
Cardiovascular Stent Types and Characteristics
China Interventional Cardiovascular Device Industry Chain
Revenue and Growth Rate of China Medical Device Industry, 2006-2012
China's Cardiovascular Stent Market Size and Growth Rate, 2007-2012
PCI Surgical Cases in China, 2002-2012
Number of Coronary Stent Implantation in China, 2002-2012
Import Ratio and Import Prices of China's Major Interventional Medical Devices, 2008
Chinese Interventional Cardiovascular Device Market Share, 2012
Gross Margin of China's Major Interventional Cardiovascular Device Companies, 2007-2012
Business Model of China Interventional Cardiovascular Device Industry
Key Policies for China Interventional Cardiovascular Device Industry, 2006-2012
Number of Hospitals in China (by Grade), 2006-May 2013
Total Medical & Health Costs and % in GDP in China, 2000-2012
Population of 65-year-old People and % in Total Population in China, 1982-2012
China's Per Capita Disposable Income of Urban Residents and Per Capita Net Income of Rural Households, 2001-2012
China's Medical Care Coverage and Spending Levels
Interventional Operation Medical Insurance Payout Ratio in Beijing, Shanghai and Guangzhou, 2011
China's Coronary Stent Market Size, 2007-2015E
List of Drug-eluting Stent Products in Chinese Market, 2010
Maximum Retail Price of Heart Stent Products in Shanghai, 2012
List of Domestic Second-generation Drug-eluting Stent Products, 2013
Interventional Supplies Bidding Price of A Hospital in Shanghai, 2012
List of Some Bare Metal Stents in Chinese Market, 2010
Bare Metal Stent Usage in China, 2009-2012
Bioabsorbable Stent Usage in China, 2009-2012
China's Interventional Cardiovascular Balloon Catheter Market Size, 2009-2012
China's Demand for Coronary Balloon Catheter, 2002-2012
Balloon Catheter Purchase Prices in Chinese Market, 2010
List of Some Rapid Exchange Balloon Dilatation Catheters in Chinese Market, 2010
Maximum Retail Price of Catheter Products in Shanghai, 2012
China's Interventional Cardiovascular Catheter Market Size, 2009-2012
Catheter Purchase Prices in Chinese Market, 2010
Listing of Guiding Catheter Products in Chinese Market, 2010
Maximum Retail Price of Catheter Products in Shanghai, 2012
China's Interventional Cardiovascular Guidewire Market Size, 2009-2012
Guidewire Purchase Prices in Chinese Market, 2010
List of Some Guidewire Products in Chinese Market, 2010
Market Size of Interventional Cardiovascular Sheath Group and Auxiliary Devices in China, 2009-2012
Average Purchase Prices of Sheath Group and Auxiliary Devices in Chinese Market, 2010
Revenue and Net Income of Johnson & Johnson, 2008-2012
Revenue Structure of Johnson & Johnson (by Product), 2012
Revenue of Cordis, 2007-2011
Johnson & Johnson Companies in China and Their Main Products
Revenue and Total Profit of Johnson & Johnson Medical (Suzhou), 2008-2009
Gross Margin of Johnson & Johnson Medical (Suzhou), 2008-2009
Total Assets and Total Liabilities of Johnson & Johnson Medical (Suzhou), 2008-2009
Revenue and Net Income of Medtronic, FY2008-FY2013
Gross Margin of Medtronic, FY2009-FY2013
Medtronic's Revenue from Cardiovascular Products and % of Total Revenue, FY2008-FY2011
Revenue Structure of Medtronic (by Product), FY2011-FY2013
Revenue Structure of Medtronic (by Region), FY2009-FY2013
Revenue and Total Profit of Medtronic (Shanghai), 2007-2008
Gross Margin of Medtronic (Shanghai), 2007-2008
Total Assets and Total Liabilities of Medtronic (Shanghai), 2007-2008
Revenue and Net Income of Boston Scientific, 2008-2012
Revenue Structure of Boston Scientific (by Product), 2009-2012
Revenue and Net Income of Abbott Laboratories, 2008-2012
Abbott's Revenue from Vascular Device Division and % of Total Revenue, 2008-2012
Revenue and Growth Rate of B. Braun Aesculap Surgical Instrument Sector, 2006-2012
Revenue and Net Income of MicroPort, 2008-2013
Revenue Structure of MicroPort (by Product), 2012
Revenue Structure of MicroPort (by Region), 2008-2012
Gross Margin of MicroPort, 2008-2013
R&D Costs and % of Total Revenue of MicroPort, 2008-2012
MicroPort's Competitive Advantage in Field of Heart Drug Stent
Key Financial Indicators of DongGuan Kewei MedicalInstrument, 2010-2011
Revenue and Net Income of MicroPort, 2012-2015
Revenue and Net Income of Lepu Medical, 2008-2013
Revenue Structure of Lepu Medical (by Product), 2008-2013
Operating Revenue Structure of Lepu Medical (by Region), 2008-2013
Gross Margin of Lepu Medical, 2008-2013
Gross Margin of Lepu Medical (by Product), 2008-2013
R&D Costs and % of Total Revenue of Lepu Medical, 2008-2012
Revenue and Net Income of Lepu Medical, 2012-2015
Revenue and Net Income of Lifetech Scientific, 2009-2013
Revenue Structure of Lifetech Scientific (by Product), 2010-2013
Revenue Structure of Lifetech Scientific (by Region), 2010-2012
Gross Margin of Lifetech Scientific, 2009-2013
R&D Costs and % of Total Revenue of Lifetech Scientific, 2010-2013
CHD (Congenital Heart Disease) Revenue of Lifetech Scientific, 2010-2013
Peripheral Vascular Revenue of Lifetech Scientific, 2010-2013
Revenue and Total Profit of JW Medical, 2007-2011
Gross Margin of JW Medical, 2007-2011
Total Assets and Total Liabilities of JW Medical, 2007-2011
Revenue and Total Profit of Liaoning Bio-medical, 2008-2009
Gross Margin of Liaoning Bio-medical, 2008-2009
Total Assets and Total Liabilities of Liaoning Bio-medical, 2008-2009
Revenue and Total Profit of OrbusNeich, 2007-2011
Gross Margin of OrbusNeich, 2007-2011
Total Assets and Total Liabilities of OrbusNeich, 2007-2011
Revenue and Total Profit of Sinomed, 2008-2011
Gross Margin of Sinomed, 2008-2011
Total Assets and Total Liabilities of Sinomed, 2008-2011
Revenue and Total Profit of SCW Medicath, 2007-2011
Gross Margin of SCW Medicath, 2007-2011
Total Assets and Total Liabilities of SCW Medicath, 2007-2011
Export Delivery Value and % of Total Revenue of SCW Medicath, 2005-2009
Revenue and Total Profit of Amtech Biotech, 2008-2012
Total Assets and Total Liabilities of Amtech Biotech, 2008-2012
Revenue and Total Profit of Starway Medical, 2009-2011
Gross Margin of Starway Medical, 2009-2011
Total Assets and Total Liabilities of Starway Medical, 2009-2011

China Dental Industry Report, 2014-2018

Oral industry refers to the medical industry chain on the basis of oral medical consumption, mainly covering oral medical apparatus (equipment and consumables) and oral medical services. As reform of ...

China Medical Monitor Industry Report, 2014-2017

With advancement of medical reform, improvement of spending power, and enhancement of health care consciousness, China’s medical monitor industry is gradually expanding. During 2007-2013, the market s...

China Independent Clinical Laboratory Industry Report, 2014-2017

The independent clinical laboratory industry starts relatively late in China, featuring a limited overall size but high-speed development. In 2013 the independent clinical laboratory market size there...

China Interventional Cardiovascular Device Industry Report,2014-2017

The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing ye...

China PTCA Balloon Market Investment Report, 2014-2016

PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. There...

China Orthopedic Instrument Industry Report, 2014-2017

Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale ...

China Hospital Development and Investment Report, 2014-2017

China hospital industry has been developing quickly in recent years, thanks to the market demand stimulus and steady progress in health care reform. The number of Chinese hospitals grew at a CAGR of 6...

China Diagnostic Reagent Industry Report, 2013-2016

With the accelerated aging of the Chinese population, the increase of personal health expenditure as well as the improved medical care facilities and government health care system, China diagnostic re...

China Hemodialysis Equipment Import and Export Report, 2013-2016

Hemodialysis equipment is the most widely used treatment apparatus in blood purification, primarily targeting patients with acute or chronic renal failure.The Chinese hemodialysis equipment market sho...

Global and China Hemodialysis Industry Report, 2013-2016

Hemodialysis, also known as artificial kidney, is a type of blood purification technology, primarily applicable to the treatment of patients with rental failure. In 2013, the global number of patient...

China Portable Medical Equipment Industry Report, 2013-2016

With the synergy of favorable policies, improvement in living standards and healthcare awareness raising, China’s portable medical device industry has shown rapid development in recent years, with mar...

China Medical Informatization Industry Report,2013-2016

Under the impetus of multiple favorable policies and market demand, China's medical informatization industry has entered a rapid development stage in recent years. As of the first half of 2013, manage...

China Aged Care Industry Report, 2013-2016

Currently, China has entered the accelerated aging period. China’s population aged 65 and above reached 131.61 million in 2013, accounting for 9.7% of total population; and the proportion will rise to...

China Pharmaceutical Equipment Industry Report, 2013-2016

After decades of development, China has become a major producer of pharmaceutical equipment in the world. Since 2010, affected by the new GMP certification and other factors, the revenue and total pro...

China Dental Industry Report, 2013-2016

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental appliances (equipments and consumables), dental medical services, etc. with...

China Medical Monitor Industry Report, 2013-2015

In 2007-2011, the Chinese medical monitor market size rose from RMB1.16 billion to RMB3.08 billion at a CAGR of 27.8%. In 2012, the figure reached RMB3.86 billion, a year-on-year increase of 25.3%, of...

China Interventional Cardiovascular Device Industry Report, 2013-2015

With the accelerated aging, the prevalence of cardiovascular diseases in China increased year by year. According to statistics of National Health and Family Planning Commission of the People’s Republi...

China Diagnostic Reagent Industry Report, 2013-2015

Driven by huge population base, intensified aging and many favorable policies, China diagnostic reagent industry has been developing rapidly. In 2008-2012, the diagnostic reagent market size presented...

2005-2014 All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号